Your browser doesn't support javascript.
loading
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia.
Steckel, Nina K; Groth, Christoph; Mikesch, Jan-Henrik; Trenschel, Rudolf; Ottinger, Hellmut; Kordelas, Lambros; Mueller-Tidow, Carsten; Schliemann, Christoph; Reicherts, Christian; Albring, Joern C; Silling, Gerda; Schmidt, Eva; Berdel, Wolfgang E; Lenz, Georg; Ditschkowski, Markus; Beelen, Dietrich W; Stelljes, Matthias.
Afiliación
  • Steckel NK; Department of Bone Marrow Transplantation, West German Cancer Centre, University Hospital of Essen, Essen, Germany.
  • Groth C; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Mikesch JH; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Trenschel R; Department of Bone Marrow Transplantation, West German Cancer Centre, University Hospital of Essen, Essen, Germany.
  • Ottinger H; Department of Bone Marrow Transplantation, West German Cancer Centre, University Hospital of Essen, Essen, Germany.
  • Kordelas L; Department of Bone Marrow Transplantation, West German Cancer Centre, University Hospital of Essen, Essen, Germany.
  • Mueller-Tidow C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Schliemann C; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Reicherts C; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Albring JC; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Silling G; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Schmidt E; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Berdel WE; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Lenz G; Cluster of Excellence EXC 1003, Cells in Motion, Muenster, Germany.
  • Ditschkowski M; Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
  • Beelen DW; Cluster of Excellence EXC 1003, Cells in Motion, Muenster, Germany.
  • Stelljes M; Translational Oncology, University Hospital Muenster, Muenster, Germany.
Br J Haematol ; 180(6): 840-853, 2018 03.
Article en En | MEDLINE | ID: mdl-29468631
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Irradiación Corporal Total / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Melfalán Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Irradiación Corporal Total / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Melfalán Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Alemania